Skip to main content

Table 4 NPC patients with juvenile (J) form of disease

From: Observational, retrospective study of a large cohort of patients with Niemann-Pick disease type C in the Czech Republic: a surprisingly stable diagnostic rate spanning almost 40 years

P

G

Sb/Cs

Year of dg

Age at death (†)/age at last follow up

First visceral symptoms (age)

First neuro-psychiatric symptoms (age)

BMS (Y/ND)

Filipin and CEL or CE (Y/ND)

Histology and AT (Y/ND)

Mutations (NPC1)predicted effect on protein

Age at dg

1

F

0

1975

29y (†)

NR

A, Ds (13y)

ND

ND

Y(AT)

ND

29y

2

M

0

1976

11y (†)

NJa, HSm (1 m)

PMRg (8y)

ND

ND

Y(AT)

ND

11y

3

F

S of 4/T4

1980

14y (†)

NR

Sp, Epi (7y)

ND

ND

Y(AT)

ND

14y

4

M

B of 3/T4

1981

20y (†)

Sm (9y)

LDs, Epi (9y)

Y

ND

Y

ND

9y

5

F

0

1981

24y (†)

HSm (8y)

LDs, Tr (8y)

Y

ND

Y

ND

10y

6

F

S of 7/T4

1989

19y (†)

NR

A, PMRg (7y)

Y

Y(F/C)

Y

c.2196dupT/c.2861C>T

7y

p.P733Sfs*9/p.S954L

7

F

S of 6/T4

1989

33y (†)

HSm (5y)

A, Ds (9y)

Y

ND

ND

c.2196dupT/c.2861C>T

9y

p.P733Sfs*9/p.S954L

8

F

0

1997

24y (†)

NR

Sp, Ds (14y)

ND

ND

Y(AT)

ND

24y

9

F

0

1997

18y

HSm (9 m)

A, Ds, BDs (7y)

Y

Y(F/C)

ND

c.1421C>T/c.2072C>T

1y

p.P474L/p.P691L

10

F

S of 2/T5

1997

38y

Sm (21y)

A, Ds (13y)

ND

Y(F/C)

ND

c.1210delC/c.1990G>A

21y

p.R404Gfs*45/p.V664M

11

M

0

1998

28y

NR

Epi, CDc (13y)

Y

Y(F/V)

ND

c.1232G>C/c.3019C>G

13y

p.R411P/p.P1007A

12

M

Cs of 20/T4

1998

21y

Sm (4y)

Ds (14y)

ND

Y(F/I)

ND

c.2861C>T/c.3557C>A

5y

p.S954L/p.R1186H

13

M

0

1999

?(†)/17y

Sm (17y)

LDs (7y)

Y

Y(F/I)

ND

c.2849T>G/c.3019C>G

17y

p.V950G/p.P1007A

14

F

S of 4/T3

2000

27y (†)

Sm (7y)

PMRg (7y)

ND

Y(F/V)

Y(AT)

c.352_353delAG/c.3019C>G

27y

p.Q119Vfs*7/p.P1007A

15

F

0

2000

27y

Sm (13y)

LDs, A (9y)

Y

Y(F/I)

ND

c.1812dupT/c.2861C>T

13y

p.A605Cfs*1/p.S954L

16

F

0

2002

25y (†)

NR

LDs, A, Dk (13y)

ND

ND

Y(AT)

c.1028G>A/c.3019C>G

25y

p.G343E/p.P1007A

17

M

0

2003

35y

Sm (23y)

A, Ds (14y)

Y

Y(F/C)

ND

c.2861C>T/c.3557G>A

24y

p.S954L/p.R1186H

18

M

B of 5/T5 &6/T5

2005

23y

Sm (14y)

LDs,Ds (14y)

ND

Y(F/V)

ND

c.2780C>T/c.2780C>T

14y

p.A927V/p.A927V

19

M

0

2006

27y

Sm (19y)

Ds, Epi (13y)

Y

ND

ND

c.1232G>C /c.2861C>T

19y

p.R411P /p.S954L

20

F

Cs of 12/T4

2007

23y

Sm (18y)

Ds, A (13y)

Y

ND

ND

c.2861C>T/c.3557G>A

18y

p.S954L/p.R1186H

  1. A ataxia, AT autopsy, B brother, BDs behaviour disorder, BMS bone marrow smear, CDc cognitive decline, CE non-LDL-cholesterol esterification test, CEL LDL-cholesterol esterification test, Cs cousin, dg diagnosis, Dk dyskinesia, Ds dysarthria, Epi epilepsia, F female, F/C classical biochemical subtype using filipin + CEL, F/I intermediate biochemical subtype using filipin + CEL, F/V variant biochemical subtype using filipin + CEL, G gender, HSm hepatosplenomegaly, LDs learning disability, m months, M male, ND not done, NJa neonatal jaundice, NR not reported, PMRg psychomotoric regression, P order of patient at the category, S sister, Sb sibling, Sm splenomegaly, Sp spasticity, T table, Tr tremor, y years, Y yes, † patient deceased, *translation stop codon in 1-letter amino acide code. Note: novel mutations are highlighted in bold font, and italics indicate decisive diagnostic method or methods (if they were performed simultaneously or in quick succession).